A number of genes have been potentially implicated in the development of MTX resistance in GTN, including dihydrofolate reductase (DHFR) (5), ATP-binding-cassette (ABC) transporter MRP1 (6), CD105 (7), Type I interferons (8), and SLAMF1 (9). Here, DHFR is linked to gestational trophoblastic neoplasm.